SGLT2i in CKD with high albuminuria: an observational real-world study

被引:0
|
作者
Svensson, Maria K. [1 ]
Bodegard, Johan [2 ]
Thuresson, Marcus [3 ]
Ambery, Philip [2 ]
机构
[1] Uppsala Univ, Uppsala, Sweden
[2] AstraZeneca, Gothenburg, Sweden
[3] Statisticon AB, Uppsala, Sweden
关键词
D O I
10.1093/ndt/gfae069.147
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
2638
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Relative and Absolute Risks of Adverse Events with Real-World Use of SGLT2 Inhibitors in CKD
    Odutayo, Ayodele
    Levin, Adeera
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (05): : 557 - 559
  • [22] Risk of CKD among patients with DM taking diuretics or SGLT2i: a retrospective cohort study in Taiwan
    Han-Jie Lin
    Pin-Yang Shih
    Stella Chin-Shaw Tsai
    Wu-Lung Chuang
    Tsai-Ling Hsieh
    Heng-Jun Lin
    Teng-Shun Yu
    Fuu-Jen Tsai
    Chiu-Ying Chen
    Kuang-Hsi Chang
    BMC Pharmacology and Toxicology, 25
  • [23] Personal Hygiene and SGLT2i
    Raha, A.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 209
  • [24] Stratifying the effects of SGLT2i
    Fernandez-Ruiz, Irene
    NATURE REVIEWS CARDIOLOGY, 2019, 16 (06) : 322 - 322
  • [25] Renal perfusion and SGLT2i
    Nielsen, Steffen Flindt
    Duus, Camilla
    Buus, Niels Henrik
    Bech, Jesper Noergaard
    Mose, Frank
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I350 - I352
  • [26] Stratifying the effects of SGLT2i
    Irene Fernández-Ruiz
    Nature Reviews Cardiology, 2019, 16 : 322 - 322
  • [27] Real-World Use of SGLT2 Inhibitors in Patients with CKD with and without Diabetes: A Population-Based Cohort Study
    Toro, Luis
    Valderrama, Josefa
    Polanco, Diego
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [28] Real world registry of use of SGLT2i in patients with HFrEF followed in a non-tertiary hospital
    Martinez Mateo, V. Virgilio
    Cejudo Del Campo, L.
    Martin Barrios, E.
    Ibanez Leal, R.
    Serrano Blano, A.
    Gadella Fernandez, A.
    Paule, A. J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 589 - 590
  • [29] Long-Term, Real-World Kidney Outcomes with SGLT2i versus DPP4i in Type 2 Diabetes without Cardiovascular or Kidney Disease
    Cohen, Cheli Melzer
    Schechter, Meir
    Rozenberg, Aliza
    Yanuv, Ilan
    Sehtman-Shachar, Dvora R.
    Fishkin, Alisa
    Rosenzweig, Doron
    Chodick, Gabriel
    Karasik, Avraham
    Mosenzon, Ofri
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (09): : 1153 - 1162
  • [30] Finerenone in Patients with CKD and T2D by SGLT2i Treatment: An Analysis of the FIDELIO-DKD Study
    Rossing, Peter
    Agarwal, Rajiv
    Anker, Stefan
    Filippatos, Gerasimos
    Pitt, Bertram
    Ruilope, Luis M.
    Chan, Juliana C.
    Kooy, Adriaan
    Mccafferty, Kieran
    Schernthaner, Guntram
    Wanner, Christoph
    Joseph, Amer
    Scheerer, Markus F.
    Scott, Charlie
    Bakris, George
    DIABETES, 2021, 70